Edition:
United States

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

62.78USD
4:00pm EDT
Change (% chg)

$-2.36 (-3.62%)
Prev Close
$65.14
Open
$64.80
Day's High
$65.00
Day's Low
$62.53
Volume
211,073
Avg. Vol
382,782
52-wk High
$73.90
52-wk Low
$15.04

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.36 -0.617
FY 2017 Dec '17 32.33 0.159
Sep '17 2.39 -0.616
Jun '17 3.58 -0.559
Mar '17 2.70 -0.541
FY 2016 Dec '16 2.34 1.395
Sep '16 1.55 -0.369
Jun '16 0.80 -0.432
Mar '16 0.48 -0.212
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 1.83 2.90 0.50 4.00
Quarter Ending Sep-18 5 4.14 9.50 0.50 4.00
Year Ending Dec-18 6 10.74 24.00 2.90 14.75
Year Ending Dec-19 6 22.12 91.10 0.00 16.87
Earnings (per share)
Quarter Ending Jun-18 6 -0.63 -0.59 -0.71 -0.62
Quarter Ending Sep-18 7 -0.63 -0.51 -0.75 -0.61
Year Ending Dec-18 7 -2.58 -2.38 -2.89 -3.01
Year Ending Dec-19 7 -2.92 -1.90 -4.13 -3.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 244.60 33.54
P/E High - Last 5 Yrs. -- 290.57 47.76
P/E Low - Last 5 Yrs. -- 100.09 25.07
Beta -- 0.74 0.79
Price to Sales (TTM) 77.66 253.05 8.28
Price to Book (MRQ) 10.47 23.78 4.21
Price to Tangible Book (MRQ) 10.62 30.85 6.00
Price to Cash Flow (TTM) -- 144.30 22.70
% Owned Institutions 40.15 12.00 2.44

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.74
Dividend Yield - 5 Year Avg -- 0.20 1.43
Dividend 5 Year Growth Rate -- 2.17 -6.29
Payout Ratio(TTM) -- 41.14 41.21

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -49.76 26.93 5.43
Sales (TTM) vs TTM 1 Yr. Ago 436.49 139.59 12.81
Sales - 5 Yr. Growth Rate -- 31.30 7.89
EPS (MRQ) vs Qtr. 1 Yr. Ago -14.11 -77.66 40.97
EPS (TTM) vs TTM 1 Yr. Ago -3,157.31 -- --
EPS - 5 Yr. Growth Rate -- 48.96 8.04
Capital Spending - 5 Yr. Growth Rate -- 36.68 7.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.55
Current Ratio (MRQ) 24.42 6.40 3.62
LT Debt to Equity (MRQ) 0.00 22.45 13.20
Total Debt to Equity (MRQ) 0.00 26.80 17.68
Interest Coverage (TTM) -2.09 -139.93 36.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.67 55.10
Gross Margin - 5 Yr. Avg. -- 55.13 52.98
EBITD Margin (TTM) -170.89 -- --
EBITD - 5 Yr. Avg -- -167.31 15.70
Operating Margin (TTM) -178.81 -893.25 -0.37
Operating Margin - 5 Yr. Avg. -- -180.81 10.89
Pre-Tax Margin (TTM) -185.68 -786.04 1.60
Pre-Tax Margin - 5 Yr. Avg. -- -184.17 11.06
Net Profit Margin (TTM) -173.71 -779.78 -1.69
Net Profit Margin - 5 Yr. Avg. -- -182.64 7.42
Effective Tax Rate (TTM) -- 15.40 29.75
Effective Tax Rate - 5 Yr. Avg. -- 19.25 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 312,220 21,874,759 727,953,282
Net Income/Employee (TTM) -542,370 -152,114 84,747,764
Receivable Turnover (TTM) 11.44 18.30 6.05
Inventory Turnover (TTM) -- 2.83 3.67
Asset Turnover (TTM) 0.11 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -19.77 -3.57 10.32
Return on Assets - 5 Yr. Avg. -- -0.71 10.99
Return on Investment (TTM) -20.70 -5.33 13.09
Return on Investment - 5 Yr. Avg. -- 2.10 14.27
Return on Equity (TTM) -27.25 -6.88 15.10
Return on Equity - 5 Yr. Avg. -- -3.17 15.63
  1 Year 3 Year 5 Year
Sales % 693.90 -- --
EPS (TTM) % 18.07 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CRISPR Therapeutics AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -6.48 -7.22 61 72
13 Week 25.03 20.21 99 36
26 Week 232.69 224.80 99 86
52 Week 333.11 283.63 99 86
YTD 177.43 169.74 99 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.47%
# of Holders: 161
Total Shares Held: 19,096,292
3 Mo. Net Change: -1,139,411
# New Positions: 74
# Closed Positions: 14
# Increased Positions: 108
# Reduced Positions: 46
# Net Buyers: 62
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.